Award recordCONTRACT

ABBOTT LABORATORIES INC.

PIID 36C24821N0698· VHA· 248-NETWORK CONTRACT OFFICE 8 (36C248)· 6630 · CHEMICAL ANALYSIS INSTRUMENTS· FY2021· $4,607,892 net obligations· UEI NH3LDK8CFAK7· IL

Description

COST PER TEST

First action · last action
2021-06-24 · 2026-01-06
Transactions
14
First transaction's obligation
$317,029
Base + all options value (sum of deltas)
$7,933,150
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
2
SDVOSB flag on record
No
Parent IDV
36F79719D0024
NAICS
334516 · ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING

Modification chain · 14 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$4,751,432$0Base award · 2021-06-24 · this action $317,029 · running total $317,029Modification P00001 · 2021-10-01 · this action $1,108,419 · running total $1,425,448Modification P00002 · 2022-10-01 · this action $1,108,419 · running total $2,533,868Modification P00003 · 2023-03-01 · this action -$50,516 · running total $2,483,352Modification P00004 · 2023-04-24 · this action $20,602 · running total $2,503,954Modification P00005 · 2023-10-01 · this action $1,129,022 · running total $3,632,976Modification P00006 · 2023-11-02 · this action $1,366 · running total $3,634,341Modification P00007 · 2023-12-19 · this action -$14,315 · running total $3,620,027Modification P00008 · 2024-03-20 · this action -$68,595 · running total $3,551,432Modification P00009 · 2024-10-01 · this action $1,200,000 · running total $4,751,432Modification P00010 · 2024-12-11 · this action $0 · running total $4,751,432Modification P00011 · 2024-12-23 · this action -$506 · running total $4,750,926Modification P00012 · 2025-04-16 · this action $0 · running total $4,750,926Modification P00013 · 2026-01-06 · this action -$143,034 · running total $4,607,892
  • Base2021-06-24+$317,029= $317,029
  • Mod P000012021-10-01+$1,108,419= $1,425,448
  • Mod P000022022-10-01+$1,108,419= $2,533,868
  • Mod P000032023-03-01-$50,516= $2,483,352
  • Mod P000042023-04-24+$20,602= $2,503,954
  • Mod P000052023-10-01+$1,129,022= $3,632,976
  • Mod P000062023-11-02+$1,366= $3,634,341
  • Mod P000072023-12-19-$14,315= $3,620,027
  • Mod P000082024-03-20-$68,595= $3,551,432
  • Mod P000092024-10-01+$1,200,000= $4,751,432
  • Mod P000102024-12-11+$0= $4,751,432
  • Mod P000112024-12-23-$506= $4,750,926
  • Mod P000122025-04-16+$0= $4,750,926
  • Mod P000132026-01-06-$143,034= $4,607,892
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2021-06-24+$317,029$317,029COST PER TEST
Mod P00001· EXERCISE AN OPTION2021-10-01+$1,108,419$1,425,448COST PER TEST
Mod P00002· EXERCISE AN OPTION2022-10-01+$1,108,419$2,533,868COST PER TEST
Mod P00003· FUNDING ONLY ACTION2023-03-01−$50,516$2,483,352COST PER TEST
Mod P00004· OTHER ADMINISTRATIVE ACTION2023-04-24+$20,602$2,503,954COST PER TEST
Mod P00005· OTHER ADMINISTRATIVE ACTION2023-10-01+$1,129,022$3,632,976COST PER TEST
Mod P00006· OTHER ADMINISTRATIVE ACTION2023-11-02+$1,366$3,634,341COST PER TEST
Mod P00007· OTHER ADMINISTRATIVE ACTION2023-12-19−$14,315$3,620,027COST PER TEST
Mod P00008· OTHER ADMINISTRATIVE ACTION2024-03-20−$68,595$3,551,432COST PER TEST
Mod P00009· EXERCISE AN OPTION2024-10-01+$1,200,000$4,751,432COST PER TEST
Mod P00010· OTHER ADMINISTRATIVE ACTION2024-12-11+$0$4,751,432COST PER TEST
Mod P00011· OTHER ADMINISTRATIVE ACTION2024-12-23−$506$4,750,926COST PER TEST
Mod P00012· OTHER ADMINISTRATIVE ACTION2025-04-16+$0$4,750,926COST PER TEST
Mod P00013· OTHER ADMINISTRATIVE ACTION2026-01-06−$143,034$4,607,892COST PER TEST

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI NH3LDK8CFAK7)

AwardOffice · PSC / listingNet obligationsFY
36C24426N1004244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$187,594FY2026
36C24426N1005244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$395,322FY2026
36C24426N1001244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$431,969FY2026
36C24426N1003244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$267,954FY2026
36C24426N1002244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$607,544FY2026
36C24426N1006244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$783,641FY2026

Other recipients under 6630 from 248-NETWORK CONTRACT OFFICE 8 (36C248) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C24826F0134ROCHE DIAGNOSTICS CORPORATION248-NETWORK CONTRACT OFFICE 8 (36C248)$685,337FY2026
36C24826F0127SIEMENS HEALTHCARE DIAGNOSTICS INC.248-NETWORK CONTRACT OFFICE 8 (36C248)$357,843FY2026
36C24826N0044BECKMAN COULTER, INC248-NETWORK CONTRACT OFFICE 8 (36C248)$346,465FY2026
36C24826N0109ROCHE DIAGNOSTICS CORPORATION248-NETWORK CONTRACT OFFICE 8 (36C248)$0FY2026
36C24826N0126QUIDELORTHO SALES COMPANY, LLC248-NETWORK CONTRACT OFFICE 8 (36C248)$110,752FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24821N0698_3600_36F79719D0024_3600 · retrieved 2026-09-26.